Harry F. Hixson, Jr.
2016
In 2016, Harry F. Hixson, Jr. earned a total compensation of $1M as Director and Former Interim Chief Executive Officer and Principal Financial Officer at Arena Pharmaceuticals, a 116% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $560,045 |
|---|---|
| Option Awards | $150,925 |
| Salary | $281,700 |
| Other | $48,395 |
| Total | $1,041,065 |
Hixson received $560K in non-equity incentive plan, accounting for 54% of the total pay in 2016.
Hixson also received $150.9K in option awards, $281.7K in salary and $48.4K in other compensation.
Rankings
In 2016, Harry F. Hixson, Jr.'s compensation ranked 8,045th out of 14,075 executives tracked by ExecPay. In other words, Hixson earned more than 42.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,045 out of 14,075 | 43rd |
Division Manufacturing | 3,073 out of 5,486 | 44th |
Major group Chemicals And Allied Products | 1,023 out of 1,900 | 46th |
Industry group Drugs | 793 out of 1,543 | 49th |
Industry Pharmaceutical Preparations | 627 out of 1,173 | 47th |
Source: SEC filing on April 28, 2017.
Hixson's colleagues
We found six more compensation records of executives who worked with Harry F. Hixson, Jr. at Arena Pharmaceuticals in 2016.
2016
Amit Munshi
Arena Pharmaceuticals
Chief Executive Officer
2016
Dominic Behan
Arena Pharmaceuticals
Chief Scientific Officer
2016
Steven Spector
Arena Pharmaceuticals
General Counsel
2016
Kevin Lind
Arena Pharmaceuticals
Chief Financial Officer
2016
Craig Audet
Arena Pharmaceuticals
Former Senior Vice President, Operations and Head of Global Regulatory Affairs
2016
Vincent Aurentz
Arena Pharmaceuticals